Corcept Therapeutics Incorporated CORT
$83.39
▼ -0.41% 24H
About
Corcept Therapeutics Incorporated is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing medications that address severe endocrine, metabolic, oncologic, and neurologic disorders. The company’s core scientific approach is based on modulating the effects of the hormone corti…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees500
TickerCORT
Statistics
Market Cap$8.95B
Revenue (TTM)$761.4M
Net Income$99.7M
Net Margin13.1%
EPS$0.82
P/E223.20
P/S10.90
P/B13.14
EV/EBITDA-1161.90
ROE7.2%
Dividend Yield—
Price$83.39
Data: Twelve Data · Revenue = mcap / P/S